DILIP K SENGUPTA

Allopathic & Osteopathic Physicians|Orthopaedic Surgery MANSFIELD, TX NPI 1184656282

General Payments — all program years on this page

$691,648.46

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 132
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $99,538.69 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $84,000.0012
Royalty or License $15,310.293
Gift $206.811
Food and Beverage $21.591

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CTL Medical Corporation $84,206.8113
Globus Medical, Inc. $15,310.293
PROVIDENCE MEDICAL TECHNOLOGY, INC. $21.591

By program year

Program yearAmountRecords
2018 $107,892.8724
2019 $95,575.5620
2020 $101,637.6913
2021 $107,344.7127
2022 $88,473.4116
2023 $91,185.5315
2024 $99,538.6917

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078223733 CTL Medical Corporation $206.81 12/20/2024 Gift Undisputed 01/23/2026 View at CMS
1078223735 CTL Medical Corporation $7,000.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223738 CTL Medical Corporation $7,000.00 02/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223741 CTL Medical Corporation $7,000.00 03/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223751 CTL Medical Corporation $7,000.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223752 CTL Medical Corporation $7,000.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223754 CTL Medical Corporation $7,000.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223756 CTL Medical Corporation $7,000.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223757 CTL Medical Corporation $7,000.00 08/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078223758 CTL Medical Corporation $7,000.00 10/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078344746 CTL Medical Corporation $7,000.00 11/07/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078451382 CTL Medical Corporation $7,000.00 12/06/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078555674 CTL Medical Corporation $7,000.00 12/23/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089606937 Providence Medical Technology, Inc. $21.59 01/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145020355 Globus Medical, Inc. $5,288.37 07/30/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145020357 Globus Medical, Inc. $4,975.15 10/30/2024 Royalty or License Undisputed 01/23/2026 View at CMS
1145020367 Globus Medical, Inc. $5,046.77 04/26/2024 Royalty or License Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.